Successful pregnancy outcome in a patient with myelofibrosis receiving ruxolitinib treatment in the first trimester

Leuk Lymphoma. 2024 Oct;65(10):1535-1537. doi: 10.1080/10428194.2024.2355558. Epub 2024 May 20.

Authors

Ivana Urosevic^{1

2}, Marina Dokic^{1

2}, Ivanka Percic^{1

2}, Amir El Farra^{1

2}, Dunja Bjelogrlic¹, Borivoj Sekulic^{1

2}

Affiliations

¹ Clinical Center of Vojvodina, Clinic of Hematology, Novi Sad, Serbia.
² Medical Faculty, Department of Internal Medicine, University of Novi Sad, Novi Sad.

PMID: 38768438
DOI: 10.1080/10428194.2024.2355558

No abstract available

Publication types

Letter
Case Reports

MeSH terms

Adult
Female
Humans
Nitriles* / therapeutic use
Pregnancy
Pregnancy Outcome*
Pregnancy Trimester, First*
Primary Myelofibrosis* / diagnosis
Primary Myelofibrosis* / drug therapy
Pyrazoles* / therapeutic use
Pyrimidines* / therapeutic use
Treatment Outcome

Substances

ruxolitinib
Pyrazoles
Nitriles
Pyrimidines